Probiotics play an important role in preventing overgrowth of potentially pathogenic bacteria and maintaining the integrity of the gut mucosal barrier. The beneficial effects of probiotics have been previously studied in adult patients with IBS. Even though most of the studies demonstrate efficacy, other studies do not support these observations. Few studies addresses the efficacy of probiotics in children with IBS. The goal of the present study was to determine whether oral administration of the probiotic Lactobacillus GG under randomized, double-blind, placebo-controlled conditions would improve symptoms of children with abdominal pain.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
140
LGG capsules: each cp containing 3 × 109 colony forming units, CFU
placebo which consisted of capsules identical in taste and appearance to the active study product except for the absence of freeze-dried LGG (and cryoprotectants)
Clinica Pediatrica
Bari, Italy
The primary outcome measure was defined as reduction of pain (both number of episodes and intensity) at the end of the intervention.
Time frame: 12 weeks and 20 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.